{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:40:33Z","timestamp":1790563233134,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.omto.2022.01.007","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T18:22:13Z","timestamp":1643739733000},"page":"486-496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Therapeutic effects of mesenchymal stem cells loaded with oncolytic adenovirus carrying decorin on a breast cancer lung metastatic mouse model"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6368-7685","authenticated-orcid":false,"given":"Yuning","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8318-2935","authenticated-orcid":false,"given":"Fanxuan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5332-3335","authenticated-orcid":false,"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8554-1855","authenticated-orcid":false,"given":"Jing","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4796-2402","authenticated-orcid":false,"given":"Han","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4811-3090","authenticated-orcid":false,"given":"Ning","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2022.01.007_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omto.2022.01.007_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2022.01.007_bib3","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/cam4.1370","article-title":"Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study","volume":"7","author":"Xiao","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.omto.2022.01.007_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2022.01.007_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1006308619659","article-title":"Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis","volume":"59","author":"Solomayer","year":"2000","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1016\/j.omto.2022.01.007_bib6","doi-asserted-by":"crossref","first-page":"27990","DOI":"10.18632\/oncotarget.15856","article-title":"Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.omto.2022.01.007_bib7","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.3390\/ijms20092272","article-title":"Molecular mechanisms of breast cancer metastasis to the lung: clinical and experimental perspectives","volume":"20","author":"Medeiros","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omto.2022.01.007_bib8","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1158\/0008-5472.CAN-07-5644","article-title":"Subtypes of breast cancer show preferential site of relapse","volume":"68","author":"Smid","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2022.01.007_bib9","doi-asserted-by":"crossref","first-page":"e975645","DOI":"10.4161\/23723556.2014.975645","article-title":"Oncosuppressive functions of decorin","volume":"2","author":"Neill","year":"2015","journal-title":"Mol. Cell Oncol."},{"key":"10.1016\/j.omto.2022.01.007_bib10","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1074\/jbc.M111.283499","article-title":"Decorin antagonizes the angiogenic network: concurrent inhibition of met, hypoxia inducible factor 1\u03b1, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3","volume":"287","author":"Neill","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omto.2022.01.007_bib11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ajpath.2012.04.029","article-title":"Decorin: a guardian from the matrix","volume":"181","author":"Neill","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omto.2022.01.007_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.addr.2015.10.016","article-title":"Decorin as a multivalent therapeutic agent against cancer","volume":"97","author":"Neill","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omto.2022.01.007_bib13","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.18632\/oncotarget.13972","article-title":"Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model","volume":"8","author":"Oh","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.omto.2022.01.007_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/hum.2018.055","article-title":"Oncolytic adenovirus rAd.DCN inhibits breast tumor growth and lung metastasis in an immune-Competent orthotopic xenograft model","volume":"30","author":"Zhao","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omto.2022.01.007_bib15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/hum.2015.098","article-title":"Systemic delivery of an oncolytic adenovirus expressing decorin for the treatment of breast cancer bone metastases","volume":"26","author":"Yang","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omto.2022.01.007_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12876-014-0198-6","article-title":"Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model","volume":"14","author":"Jang","year":"2014","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.omto.2022.01.007_bib17","doi-asserted-by":"crossref","first-page":"3618217","DOI":"10.1155\/2019\/3618217","article-title":"Mesenchymal stem cells exhibit both a proinflammatory and anti-inflammatory effect on saccular aneurysm formation in a rabbit model","volume":"2019","author":"Avery","year":"2019","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.omto.2022.01.007_bib18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.bbrc.2019.07.101","article-title":"Therapeutic effect of human umbilical cord blood mesenchymal stem cells combined with G-CSF on rats with acute liver failure","volume":"517","author":"Chen","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omto.2022.01.007_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13287-019-1320-z","article-title":"The growth inhibitory effect of human gingiva-derived mesenchymal stromal cells expressing interferon-\u03b2 on tongue squamous cell carcinoma cells and xenograft model","volume":"10","author":"Du","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.omto.2022.01.007_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.semcancer.2019.06.003","article-title":"The multifaceted role of mesenchymal stem cells in cancer","volume":"60","author":"Timaner","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.omto.2022.01.007_bib21","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/jcp.29095","article-title":"Umbilical cord-derived mesenchymal stromal\/stem cells expressing IL-24 induce apoptosis in gliomas","volume":"235","author":"Fan","year":"2020","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.omto.2022.01.007_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2018.00259","article-title":"Application of mesenchymal stem cells for therapeutic agent delivery in anti-tumor treatment","volume":"9","author":"Chulpanova","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omto.2022.01.007_bib23","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1089\/scd.2011.0151","article-title":"Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer","volume":"21","author":"Bitsika","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.omto.2022.01.007_bib24","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1634\/stemcells.2007-1006","article-title":"Concise review: adult multipotent stromal cells and cancer: risk or benefit?","volume":"26","author":"Lazennec","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.omto.2022.01.007_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s13402-019-00459-7","article-title":"The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges","volume":"42","author":"Cortes-Dericks","year":"2019","journal-title":"Cell Oncol. (Dordr)"},{"key":"10.1016\/j.omto.2022.01.007_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1158\/2159-8290.CD-NB2015-158","article-title":"First oncolytic viral therapy for melanoma","volume":"6","author":"Poh","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omto.2022.01.007_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40265-015-0522-7","article-title":"Talimogene laherparepvec: first global approval","volume":"76","author":"Greig","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.omto.2022.01.007_bib28","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1089\/hum.2019.059","article-title":"An oncolytic adenovirus targeting transforming growth factor \u03b2 inhibits protumorigenic signals and produces immune activation: a novel approach to enhance anti-PD-1 and anti-CTLA-4 therapy","volume":"30","author":"Yang","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omto.2022.01.007_bib29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1089\/hum.2017.033","article-title":"An oncolytic adenovirus encoding decorin and granulocyte macrophage colony stimulating factor inhibits tumor growth in a colorectal tumor model by targeting pro-tumorigenic signals and via immune activation","volume":"28","author":"Liu","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omto.2022.01.007_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymthe.2006.02.011","article-title":"A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer","volume":"14","author":"Small","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2022.01.007_bib31","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1200\/JCO.2003.09.114","article-title":"Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer","volume":"21","author":"Hamid","year":"2003","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omto.2022.01.007_bib32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/156652311796150372","article-title":"Adenoviral vector immunity: its implications and circumvention strategies","volume":"11","author":"Ahi","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omto.2022.01.007_bib33","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/mt.2014.80","article-title":"Ad5\/48 hexon oncolytic virus expressing sTGF\u03b2RIIFc produces reduced hepatic and systemic toxicities and inhibits prostate cancer bone metastases","volume":"22","author":"Xu","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2022.01.007_bib34","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/mt.2012.162","article-title":"Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery","volume":"20","author":"Coughlan","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2022.01.007_bib35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-03-208835","article-title":"Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer","volume":"114","author":"Alba","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omto.2022.01.007_bib36","first-page":"6","article-title":"Mesenchymal stem cells as delivery vectors for anti-tumor therapy","volume":"2","author":"Li","year":"2015","journal-title":"Stem Cell Investig."},{"key":"10.1016\/j.omto.2022.01.007_bib37","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.20051921","article-title":"Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma","volume":"203","author":"Khakoo","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omto.2022.01.007_bib38","first-page":"159","article-title":"Human adipose tissue-derived mesenchymal stem cells inhibit melanoma growth in\u00a0vitro and in\u00a0vivo","volume":"35","author":"Ahn","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.omto.2022.01.007_bib39","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1158\/0008-5472.CAN-18-3900","article-title":"Mesenchymal stem cell-mediated delivery of an oncolytic adenovirus enhances antitumor efficacy in hepatocellular carcinoma","volume":"79","author":"Yoon","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2022.01.007_bib40","doi-asserted-by":"crossref","first-page":"E6157","DOI":"10.1073\/pnas.1700363114","article-title":"Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas","volume":"114","author":"Du","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.omto.2022.01.007_bib41","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1021\/mp200161f","article-title":"A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma","volume":"8","author":"Ahmed","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omto.2022.01.007_bib42","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13046-019-1219-7","article-title":"The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming","volume":"38","author":"Liu","year":"2019","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.omto.2022.01.007_bib43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41419-019-1508-2","article-title":"Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5","volume":"10","author":"Nishikawa","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omto.2022.01.007_bib44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/346281a0","article-title":"Negative regulation of transforming growth factor-beta by the proteoglycan decorin","volume":"346","author":"Yamaguchi","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.omto.2022.01.007_bib45","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGFbeta","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omto.2022.01.007_bib46","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ni.2388","article-title":"TGF-\u03b2 is responsible for NK cell immaturity during ontogeny and increased susceptibility to infection during mouse infancy","volume":"13","author":"Marcoe","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omto.2022.01.007_bib47","first-page":"699","article-title":"TGF-\u03b2 signaling: a complex role in tumorigenesis (Review)","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.omto.2022.01.007_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.omto.2020.07.003","article-title":"Myxoma virus-loaded mesenchymal stem cells in experimental oncolytic therapy of murine pulmonary melanoma","volume":"18","author":"Jazowiecka-Rakus","year":"2020","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.omto.2022.01.007_bib49","first-page":"1017","article-title":"Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials","volume":"91","author":"Lu","year":"2006","journal-title":"Haematologica"}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770522000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770522000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:28:59Z","timestamp":1762496939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770522000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":49,"alternative-id":["S2372770522000110"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2022.01.007","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effects of mesenchymal stem cells loaded with oncolytic adenovirus carrying decorin on a breast cancer lung metastatic mouse model","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2022.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}